The limited plastic and regenerative capabilities of axons in the adult mammalian CNS can be enhanced by the application of a monoclonal antibody (mAb), IN-1, raised against the myelinassociated neurite growth inhibitor Nogo-A. The aim of the present study was to investigate the effects of this treatment on the functional recovery of adult rats with a dorsal overhemisection of the spinal cord. Directly after injury, half of the animals were implanted with mAb IN-1-secreting hybridoma cells, whereas the others received cells secreting a control antibody (anti-HRP). A broad spectrum of locomotor tests (open field locomotor) score, grid walk, misstep withdrawal response, narrow-beam crossing) was used to characterize locomotor recovery during the 5 weeks after the injury. In all behavioral tests, the recovery in the mAb IN-1-treated group was significantly augmented compared with the control antibodytreated rats. EMG recordings of flexor and extensor muscles during treadmill walking confirmed the improvement of the locomotor pattern in the mAb IN-1-treated rats; step-cycle duration, rhythmicity, and coupling of the hindlimbs were significantly improved. No differences between the two groups with regard to nociception were observed in the tail flick test 5 weeks after the operation. These results indicating improved functional recovery suggest that the increased plastic and regenerative capabilities of the CNS after Nogo-A neutralization result in a functionally meaningful rewiring of the motor systems.
Key words: spinal cord injury; functional recovery; locomotion; Nogo-A; regeneration; plasticity; ratsSpontaneous regeneration of injured axons or plastic rearrangements of spared fiber systems after spinal cord injury in mammals are very limited. The major reasons for this poor spontaneous repair capacity seem to be the insufficient growth response of neurons to injury, the growth-inhibitory components of the adult CNS tissue, and the formation of cysts and scar tissue at the injury site. Attempts to overcome local barriers by grafting peripheral nerve bridges (Cheng et al., 1996), Schwann cells (Li and Raisman, 1994;Xu et al., 1995), or olfactory ensheathing cells (Li et al., 1997;Ramon-Cueto et al., 2000) have led to regenerative fiber growth and in some instances to behavioral recovery in animal models of spinal cord injury, although the mechanistic understanding of this recovery remains incomplete because of the complexity of these interventions; Schwann cells and olfactory ensheathing glia are also important sources of trophic factors and extracellular matrix molecules (Guénard et al., 1993;Franklin and Barnett, 2000). Attempts to increase the neuronal growth response by local applications of neurotrophic factors to spinal cord injury sites have led to increased sprouting of CNS fibers and dorsal root axons (Schnell et al., 1994;Grill et al., 1997;Kobayashi et al., 1997;Liu et al., 1999;Ramer et al., 2000). In addition, neutralization of the myelin-associated neurite growth inhibitor Nogo-A (Chen et al., 2000) ...